Search results
Tasuku Honjo (本庶 佑, Honjo Tasuku, born January 27, 1942) is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). [3]
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
Tasuku Honjo. The Nobel Prize in Physiology or Medicine 2018. Born: 27 January 1942, Kyoto, Japan. Affiliation at the time of the award: Kyoto University, Kyoto, Japan. Prize motivation: “for their discovery of cancer therapy by inhibition of negative immune regulation”. Prize share: 1/2.
3 days ago · Tasuku Honjo, Japanese immunologist who contributed to the discovery of mechanisms and proteins critical to the regulation of immune responses and whose work led to the development of novel immunotherapies against cancer. Honjo received a share of the 2018 Nobel Prize for Physiology or Medicine.
Oct 1, 2018 · In 1992, a few years before Allison’s discovery, Tasuku Honjo discovered PD-1, another protein expressed on the surface of T-cells. Determined to unravel its role, he meticulously explored its function in a series of elegant experiments performed over many years in his laboratory at Kyoto University.
Oct 1, 2018 · James Allison and Tasuku Honjo pioneered treatments that unleash the body’s own immune system to attack cancer cells.
Dr. Tasuku Honjo, awarded Keio Medical Science Prize. On September 12, Keio University announced the 21st Keio Medical Science Prize laureates, and Dr. Tasuku Honjo (Medical Scientist, Professor of Kyoto University, 2016 Kyoto Prize laureate in Basic Sciences) was selected.
Oct 1, 2018 · American James Allison and Japan’s Tasuku Honjo have won the 2018 Nobel Prize in Medicine for a pioneering approach to cancer treatment. The Nobel committee said the pair’s research – which ...
Tasuku Honjo. Deputy Director-General and Distinguished Professor. View more details. Research Fields. Molecular Immunology. Research Overview. Honjo is well known for his discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.
Oct 1, 2018 · Stopping cancer by removing brakes on the immune system has earned James P. Allison of the University of Texas MD Anderson Cancer Center in Houston and Tasuku Honjo of Kyoto University in Japan...
